Atlas Trials

Celcuity Inc

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Celcuity Inc

RecordFirmDate
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) (NCT06757634)Celcuity Inc2025-07-24
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer (NCT06190899)Celcuity Inc2024-01-01
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) (NCT05501886)Celcuity Inc2022-12-08

Track Celcuity Inc automatically

Every clearance here is in the API, with alerts when new ones post.